Eva Dawin

Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

Alexander Duscha, Barbara Gisevius, Sarah Hirschberg et al. · Cell · 2020 · 630 citations · Full text

Life Sciences, Immunology, Neurology +16

Time to Disability Milestones and Annualized Relapse Rates in <scp>NMOSD</scp> and <scp>MOGAD</scp>

Ankelien Duchow, Judith Bellmann–Strobl, Tim Friede et al. · Annals of Neurology · 2023 · 66 citations · Full text

Medicine, Neurology, Neurodegeneration +14

LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleus

Zhixiao Wu, Lena A. Berlemann, Verian Bader et al. · The EMBO Journal · 2022 · 35 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation

Tilman Schneider‐Hohendorf, Christian Wünsch, Simon Falk et al. · Brain · 2024 · 32 citations · Full text

Life Sciences, Immunology, Neurology +12

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

Vivien Häußler, Corinna Trebst, Daniel Engels et al. · Journal of Neurology Neurosurgery & Psychiatry · 2024 · 24 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15